| Aldosterone and the Heart: From Basic Research to Clinical Evidence. | |
| | |
MedLine Citation:
|
PMID: 22095099 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Recent views suggest that long-term exposure to elevated aldosterone concentrations might result in cardiac, vascular, renal, and metabolic sequelae that occur independent of the blood pressure level. Indirect evidence of the untoward effects of aldosterone on the heart has been clearly established in clinical studies that have tested the effects of mineralocorticoid receptor antagonists in the treatment of systolic heart failure. As it has become clear in recent years, the interaction between aldosterone and the heart has to deal with additional actions of the hormone on specific cell types, cellular mechanisms, and molecules that are involved in regulation of tissue responses, leading to hypertrophy, remodeling, and fibrosis. The majority of these effects are mediated by activation of the mineralocorticoid receptors that are expressed in cardiomyocytes and cardiac fibroblasts, and mediate the genomic effects of the hormone. Evidence of interactions between aldosterone and the heart that occur independent of the renal effects of aldosterone, however, is not limited to the context of systolic heart failure and observations obtained in other disease states have led, together with findings of animal studies, to a better understanding of the potential benefits of aldosterone antagonists. In this narrative overview, we highlight the most recent findings that have been obtained in experimental animal models and in clinical conditions that include, in addition to systolic heart failure, primary aldosteronism, essential hypertension, diastolic heart failure, and arrhythmia. |
| | |
Authors:
|
C Catena; G Colussi; L Marzano; L A Sechi |
Related Documents
:
|
6401829 - Change in coronary venous po2 following myocardial infarction in unanesthetized dogs. 6094639 - Contrast echocardiography in acute myocardial ischemia: i. in vivo determination of tot... 12598239 - Dexmedetomidine decreases perioperative myocardial lactate release in dogs. 655089 - Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial in... 3370389 - Pentoxifylline does not reduce infarct size in a canine model of acute myocardial infar... 7388689 - Myocardial perfusion abnormalities in carbon monoxide poisoned dogs. 23271789 - Infarct size determines myocardial uptake of cd34+ cells in the peri-infarct zone: resu... 3506089 - The human heart: vault of the soul or pump? 6605329 - Cardiac catheterization after an acute myocardial infarction. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-17 |
Journal Detail:
|
Title: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme Volume: - ISSN: 1439-4286 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0177722 Medline TA: Horm Metab Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association of cognitive function and risk for elder abuse in a community-dwelling population.
Next Document: Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcin...